SKERRA ARNE has a total of 15 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are MI SHA, SHANDONG BOAN BIOTECHNOLOGY CO LTD and CUNNINGHAM MARK.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | Germany | 1 | |
#6 | Ireland | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Skerra Arne | 14 |
#2 | Stibora Thomas | 4 |
#3 | Schlehuber Steffen | 4 |
#4 | Beste Gerald | 4 |
#5 | Schmidt Frank | 4 |
#6 | Schlapschy Martin | 2 |
#7 | Huelsmeyer Martin | 1 |
#8 | Eichinger Andreas | 1 |
#9 | Kim Hyun-Jin | 1 |
#10 | Binder Uli | 1 |
Publication | Filing date | Title |
---|---|---|
US2013331550A1 | Recombinant bacterial lipocalin blc and uses thereof | |
US2010160612A1 | Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4 | |
DE19926068C1 | Muteins of the bilin binding protein |